MYRIAD GENETICS, INC. Public Float
MYRIAD GENETICS, INC. (MYGN) had Public Float of $494.05 million as of 2025-06-30, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-24
- 2025-06-30: Entity Public Float $494.05M.
- 2024-06-28: Entity Public Float $2.22B.
- 2023-06-30: Entity Public Float $1.90B.
- 2022-06-30: Entity Public Float $1.47B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $494.05M 10-K · filed 2026-02-24 |
| 2024-06-28 | $2.22B 10-K · filed 2025-02-28 |
| 2023-06-30 | $1.90B 10-K · filed 2024-02-28 |
| 2022-06-30 | $1.47B 10-K · filed 2023-03-01 |
| 2021-06-30 | $2.38B 10-K · filed 2022-02-25 |
| 2020-06-30 | $847.19M 10-KT · filed 2021-03-16 |
| 2019-12-31 | $2.03B 10-K · filed 2020-08-13 |
| 2018-12-31 | $2.13B 10-K · filed 2019-08-13 |
| 2017-12-31 | $2.33B 10-K · filed 2018-08-24 |
| 2016-12-31 | $1.10B 10-K · filed 2017-08-09 |
| 2015-12-31 | $3.03B 10-K · filed 2016-08-10 |
| 2014-12-31 | $2.42B 10-K · filed 2015-08-12 |
| 2013-12-31 | $1.55B 10-K · filed 2014-08-13 |
| 2012-12-31 | $2.21B 10-K · filed 2013-08-14 |
| 2011-12-31 | $1.76B 10-K · filed 2012-08-15 |
| 2010-12-31 | $2.04B 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |